← Insider buys
CORT

Corcept Therapeutics Incorporated · Healthcare

Director and 10% owner Patrick G Enright sold $1.7M of Corcept Therapeutics Incorporated

Sold$1,669,606
$9.55Price
174,847Shares
−1%Stake

What CORT did after the filing

Prices for CORT after this filing aren't in yet.

Traded Tue, Nov 15. Filed Thu, Nov 17, 11:36 AM ET, during the session. Not investment advice.